Advanced BioScience Laboratories, Inc. (ABL), a global Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) for biotherapeutics, oncolytics and vaccines, a subsidiary of the French bioindustrial group Institut Mérieux, announced today that it has completed the aseptic fill/finish of a novel COVID-19 vaccine candidate for a confidential customer.
April 15, 2020
· 2 min read